Diabetic nephropathy--clinical picture and treatment guidelines
Zander, E.; Conde, N.; Precht, K.; Schulz, B.
Zeitschrift für Arztliche Fortbildung 81(18): 933-939
1987
ISSN/ISBN: 0044-2178 PMID: 3321725 Document Number: 299224
Document emailed within 1 workday
Related Documents
Bakris, G.L. 2003: The evolution of treatment guidelines for diabetic nephropathy. Strategies integrate JNC VI, more recent protocols Postgraduate Medicine 113(5): 35-40 43-4 50Nicholls, K. 2007: Prevention of progression of kidney disease: diabetic nephropathy - CARI guidelines Australian Family Physician 36(3): 137-138
Koivisto, V.; Groop, P.H.; Huttunen, N.P.; Kivekäs, J.; Pasternack, A.; Uusitupa, M.; Viikari, J. 1997: Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of the Finnish Diabetes Organization Nordisk Medicin 112(5): 154-162
1994: Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy Der Internist 35(6 Alpha-Liponsa): 1-4
Friedman, E.A. 1983: Clinical imperatives in diabetic nephropathy Kidney International. Suppl 14: S
Raszeja-Wanic, B. 1973: Morphological and clinical features of diabetic nephropathy Przeglad Lekarski 30(5): 466-467
Conti, A.A. 2002: Diabetic nephropathy. A historical, clinical and diagnostic framework Minerva Medica 93(5): 347-355
Griaznova, I.M.; Bolkhovitinova, L.M.; Vtorova, V.G. 1972: Clinical picture and morphology of diabetic embryopathy Voprosy Okhrany Materinstva i Detstva 17(11): 22-27
Agarwal, D.K. 2002: Diabetic nephropathy--prevention and treatment Journal of the Indian Medical Association 100(3): 158-60 162-3
Zimlichman, R.R.; Zlotnik, M.; Chaimovitz, C. 1983: Treatment of end-stage diabetic nephropathy Harefuah 104(3): 103-106
Philips, J.C.; Weekers, L.; Scheen, A.J. 2001: Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy Revue Medicale de Liege 56(2): 126-128
Arima, S.; Abe, K.; Kudo, K.; Tsunoda, K.; Kohzuki, M.; Imai, Y.; Saito, T.; Sato, H.; Yokozawa, S.; Yoshinaga, K. 1991: The treatment of hypertensive patients with renal insufficiency--a comparison of the blood pressure management in patients with diabetic nephropathy and patients with hypertensive nephropathy Nihon Jinzo Gakkai Shi 33(10): 1001-1009
Ito, S. 2010: Treatment strategies according to the stage of diabetic nephropathy Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 465-471
Saito, T. 2011: Treatment and prognosis of idiopathic membranous nephropathy in guidelines for nephrotic syndrome Nihon Jinzo Gakkai Shi 53(5): 708-712
Gohda, T. 2016: Treatment of diabetic nephropathy, particularly focusing on drug therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 202-206
Chantrel, F.; Bouiller, M.; Kolb, I.; Hannedouche, T. 2000: Antihypertensive treatment in type II diabetes and diabetic nephropathy Nephrologie 21(2): 47-55
Goldstein, D.E. 1994: Diabetic nephropathy. Is a pound of treatment better than an ounce of prevention? Missouri Medicine 91(6): 291
Murray, K.M. 1991: Calcium-channel blockers for treatment of diabetic nephropathy Clinical Pharmacy 10(11): 862-865
Watschinger, B.H.; Kührer, I.; Mayer, G.; Graf, H. 1988: Results of chronic hemodialysis treatment in patients with diabetic nephropathy Wiener Klinische Wochenschrift 100(3): 78-82
Matsubara, M.; Taguma, Y.; Kurosawa, K.; Hotta, O.; Suzuki, K.; Ishizaki, M. 1990: Effect of camostat mesilate for the treatment of advanced diabetic nephropathy Journal of Laboratory and Clinical Medicine 116(2): 206-210